Table 1.
WT |
RSK3–/–
|
RAF1L613V/+
|
RSK3–/–;RAF1L613V/+ |
ANOVA |
|||||
---|---|---|---|---|---|---|---|---|---|
n | 22 | 15 | 16 | 8 | |||||
LVPW;d | mm | 0.57 ± 0.01 | 0.61 ± 0.02 | 0.68 ± 0.02 | † † † | 0.58 ± 0.03 | * | ‡ ‡ ‡ | |
LVPW;s | mm | 0.86 ± 0.02 | 0.92 ± 0.03 | 1.03 ± 0.04 | † † † | 0.92 ± 0.04 | ‡ ‡ | ||
LVAW;d | mm | 0.65 ± 0.02 | 0.67 ± 0.02 | 0.70 ± 0.03 | 0.63 ± 0.04 | ||||
LVAW;s | mm | 1.00 ± 0.04 | 1.02 ± 0.05 | 1.16 ± 0.05 | 1.00 ± 0.07 | ||||
LVID;d | mm | 3.48 ± 0.05 | 3.59 ± 0.05 | 3.81 ± 0.06 | † † † | 3.77 ± 0.11 | † | ‡ ‡ ‡ | |
LVID;s | mm | 2.40 ± 0.07 | 2.46 ± 0.09 | 2.49 ± 0.08 | 2.56 ± 0.14 | ||||
ID:(PW + AW) | 2.90 ± 0.10 | 2.82 ± 0.10 | 2.80 ± 0.09 | 3.14 ± 0.14 | |||||
LV Vol;d | μL | 51 ± 2 | 54 ± 2 | 63 ± 2 | † † † | § | 61 ± 4 | † | ‡ ‡ ‡ |
LV Vol;s | μL | 21 ± 2 | 22 ± 2 | 23 ± 2 | 24 ± 3 | ||||
EF | % | 48 ± 4 | 60 ± 2 | 64 ± 2 | † † | 61 ± 3 | ‡ ‡ | ||
FS | % | 31 ± 1 | 32 ± 2 | 35 ± 1 | 32±2 | ||||
LV mass | mg | 52 ± 2 | 59 ± 2 | 72 ± 3 | † † † | § § | 60 ± 5 | a | ‡ ‡ ‡ |
BW | g | 13.1 ± 0.4 | 14.0 ± 0.3 | 13.5 ± 0.3 | 13.5 ± 0.6 | ||||
LV mass/BW | mg/g | 4.0 ± 0.1 | 4.2 ± 0.1 | 5.3 ± 0.2 | † † † | § § § | 4.4 ± 0.3 | * | ‡ ‡ ‡ |
LVPW, left ventricular posterior wall thickness; LVAW, left ventricular anterior wall thickness; LVID, left ventricular internal diameter; d, diastole; s, systole; ID:(PW + AW) = LVID;d / (LVPW;d + LVAW;d); Vol, volume; EF, ejection fraction; FS, fractional shortening; BW, body weight. All data are mean ± s.e.m.
p-Value vs. WT.
p-Value vs. RSK3–/–.
p-Value vs. Raf1L613V/+.
p = 0.07.